Crizotinib

• Description:

  Crizotinib (PF-02341066; PF-2341066) is a potent, selective, orally bioavailable, ATP-competitive inhibitor of c-Met catalytic activity with Ki of 4 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  450.3367

• Molecular Formula:

  C21H22Cl2FN5O

• Notes:

  Research use only, not for human use.

• Receptor:

  ALK|c-Met

• CAS Number:

  877399-52-5